These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25024870)

  • 1. Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non-Typhoidal Salmonella Species in Korea: A KONSAR Study Conducted in 2011.
    Yong D; Shin HB; Kim YK; Cho J; Lee WG; Ha GY; Choi TY; Jeong SH; Lee K; Chong Y;
    Infect Chemother; 2014 Jun; 46(2):84-93. PubMed ID: 25024870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.
    Lee K; Kim MN; Kim JS; Hong HL; Kang JO; Shin JH; Park YJ; Yong D; Jeong SH; Chong Y;
    Yonsei Med J; 2011 Sep; 52(5):793-802. PubMed ID: 21786445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004.
    Lee K; Lim CH; Cho JH; Lee WG; Uh Y; Kim HJ; Yong D; Chong Y;
    Yonsei Med J; 2006 Oct; 47(5):634-45. PubMed ID: 17066507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002.
    Lee K; Kim YA; Park YJ; Lee HS; Kim MY; Kim EC; Yong D; Chong Y;
    Yonsei Med J; 2004 Aug; 45(4):598-608. PubMed ID: 15344199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.
    Lee K; Lee MA; Lee CH; Lee J; Roh KH; Kim S; Kim JJ; Koh E; Yong D; Chong Y;
    Yonsei Med J; 2010 Nov; 51(6):901-11. PubMed ID: 20879058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
    Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001.
    Lee K; Jang SJ; Lee HJ; Ryoo N; Kim M; Hong SG; Chong Y;
    J Korean Med Sci; 2004 Feb; 19(1):8-14. PubMed ID: 14966334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018].
    Li SG; Liao K; Su DH; Zhuo C; Chu YZ; Hu ZD; Xu XL; Zhang R; Liu WE; Lu BH; Zeng J; Jin Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3775-3783. PubMed ID: 33379842
    [No Abstract]   [Full Text] [Related]  

  • 10. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017.
    Vu TVD; Choisy M; Do TTN; Nguyen VMH; Campbell JI; Le TH; Nguyen VT; Wertheim HFL; Pham NT; Nguyen VK; van Doorn HR;
    Antimicrob Resist Infect Control; 2021 May; 10(1):78. PubMed ID: 33971969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M;
    Jpn J Antibiot; 2012 Jun; 65(3):181-206. PubMed ID: 23173294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Korean Nationwide Surveillance of Antimicrobial Resistance of Bacteria in 1998.
    Lee K; Chang CL; Lee NY; Kim HS; Hong KS; Cho HC
    Yonsei Med J; 2000 Aug; 41(4):497-506. PubMed ID: 10992812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015.
    Kim D; Ahn JY; Lee CH; Jang SJ; Lee H; Yong D; Jeong SH; Lee K
    Ann Lab Med; 2017 May; 37(3):231-239. PubMed ID: 28224769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli.
    Lee KW; Kim MY; Kang SH; Kang JO; Kim EC; Choi TY; Chong YS;
    Yonsei Med J; 2003 Aug; 44(4):571-8. PubMed ID: 12950110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
    Karlowsky JA; Draghi DC; Jones ME; Thornsberry C; Friedland IR; Sahm DF
    Antimicrob Agents Chemother; 2003 May; 47(5):1681-8. PubMed ID: 12709340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the microbial species, antimicrobial sensitivity and drug resistance in 2652 patients of nursing hospital.
    Yang W; Ji X
    Heliyon; 2020 May; 6(5):e03965. PubMed ID: 32490228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance of selected invasive bacteria in a tertiary care center: results of a prospective surveillance study.
    Djuric O; Jovanovic S; Stosovic B; Tosic T; Jovanovic M; Markovic-Denic L
    J Infect Dev Ctries; 2016 Dec; 10(12):1325-1331. PubMed ID: 28036312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.